"Genetics Played Role in Rare Blood Clots Linked to COVID-19 Vaccines, Researchers Find"

So what were the odds for otherwise healthy people with this genetic "predisposition"? What was their risk-benefit profile - 100:0? Besides...

“Genetics Played Role in Rare Blood Clots Linked to COVID-19 Vaccines, Researchers Find” (Times, 2024.05.15):

Rare but deadly blood clots tied to Johnson & Johnson and AstraZeneca Plc’s Covid-19 shots were caused by an autoimmune reaction that some people are predisposed to, researchers found, a discovery that they say will shape development of future vaccines.

Adenovirus-based vaccines, like the J&J and AstraZeneca shots that were later pulled from the market, contain a component that, in genetically susceptible people, can trigger the production of unusually structured antibodies against a protein involved in blood clotting, scientists said Wednesday in a letter to the New England Journal of Medicine.

So, all those with “genetic predisposition” have been successfully eliminated from the human gene pool, I gather? Win-win! And, if anything, solely the adenovirus-based jabs are to blame for the snafu?

The immune reaction linked to the shot is “a new disease,”

Or are “the shots” “a new disease”?

I vaguely remember that all the way back in April 2024 (ancient times), this study, “COVID-19 vaccines and adverse events of special interest: A multinational Global Vaccine Data Network (GVDN) cohort study of 99 million vaccinated individuals” provided these statistics in Supplement Table 12 for Thrombocytopenia (THR) and Idiopathic Thrombocytopenia (ITP) for all jabs:

Is it just me, or did Pfizer and Moderna jabs actually outperform AstraZeneca and J&J in Thrombocytopenia (THR) department in the 1st jab, and then Pfizer and Moderna knocked the ball out of the park in Jab 5, and then Pfizer in Jab 6?

And didn’t Pfizer go for a killing in Jabs 5-7 in Idiopatic Thrombocytopenia (ITP) department, being a suspect already with the 1st jab?

And if Pulmonary Embolism (PEM) is also nothing to sneeze about, didn’t Pfizer and Moderna took over from AstraZeneca starting with Jab 5?

What about Cerebral Venous Sinus Thrombosis (CVST) - a fine condition in its own right? Just look at the stellar Pfizer result in Jab 6 (who’s counting), and India’s Novavax in Jab 3?

Last but not least, Splanchic Vein Thrombosis (SVT): Moderna and Pfizer beat AstraZeneca and J&J right out of the gate in Jabs 1 and 2, and Pfizer is allowed to run around the stadium in Jab 6, with all other contenders retiring.

Are we that forgetful?